Current Ratio in % of BioXcel Therapeutics, Inc. from Q3 2018 to Q3 2025

Taxonomy & unit: ratio: %
Description: The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
Summary: BioXcel Therapeutics, Inc. quarterly Current Ratio history and change rate from Q3 2018 to Q3 2025.
BioXcel Therapeutics, Inc. Current Ratio for the quarter ending 30 Sep 2025 was 122 %, a 48.7% decline year-over-year.

Current Ratio, Quarterly (%)

Current Ratio, YoY Quarterly Change (%)

BioXcel Therapeutics, Inc. Quarterly Current Ratio (%)

Period	Value	YoY Chg	Change %	Date
Q3 2025	122	-116	-48.7%	30 Sep 2025
Q2 2025	139	-113	-44.9%	30 Jun 2025
Q1 2025	186	-108	-36.6%	31 Mar 2025
Q4 2024	216	-158	-42.2%	31 Dec 2024
Q3 2024	238	-217	-47.7%	30 Sep 2024
Q2 2024	252	-383	-60.3%	30 Jun 2024
Q1 2024	293	-532	-64.4%	31 Mar 2024
Q4 2023	374	-599	-61.6%	31 Dec 2023
Q3 2023	454	-770	-62.9%	30 Sep 2023
Q2 2023	635	-772	-54.9%	30 Jun 2023
Q1 2023	825	-813	-49.6%	31 Mar 2023
Q4 2022	972	-754	-43.7%	31 Dec 2022
Q3 2022	1.22K	-626	-33.8%	30 Sep 2022
Q2 2022	1.41K	-343	-19.6%	30 Jun 2022
Q1 2022	1.64K	+371	+29.2%	31 Mar 2022
Q4 2021	1.73K	+657	+61.5%	31 Dec 2021
Q3 2021	1.85K	+1.06K	+133%	30 Sep 2021
Q2 2021	1.75K	+1.25K	+247%	30 Jun 2021
Q1 2021	1.27K	+752	+146%	31 Mar 2021
Q4 2020	1.07K	+608	+132%	31 Dec 2020
Q3 2020	793	+236	+42.4%	30 Sep 2020
Q2 2020	504	-241	-32.4%	30 Jun 2020
Q1 2020	516	-692	-57.3%	31 Mar 2020
Q4 2019	461	-1.15K	-71.4%	31 Dec 2019
Q3 2019	557	-1.01K	-64.4%	30 Sep 2019
Q2 2019	745			30 Jun 2019
Q1 2019	1.21K			31 Mar 2019
Q4 2018	1.61K			31 Dec 2018
Q3 2018	1.56K			30 Sep 2018

* An asterisk sign (*) next to the value indicates that the value is likely invalid.